Please be informed that Onxeo SA will be admitted to trading and official listing on NASDAQ OMX Copenhagen. First day of trading is 1 August 2014.
The merger between Onxeo (previously BioAlliance Pharma SA) and Topotarget has been adopted at the companies’ shareholder meetings and approved by the relevant authorities. Topotarget is the dis-continuing company. Onxeo SA has its primary listing on Euronext Paris.
ISIN: | FR0010095596 |
Name: | Onxeo |
Volume: | 31,482,333 shares (DKK 7,870,583.25) |
Face value: | EUR 0.25 |
Currency: | EUR |
Trade currency: | DKK |
Voting rights of listed capital: | Full |
Financial year: | 1 January to 31 December |
Unlisted capital: | EUR 0 |
French Organization number: | 410 910 095 RCS |
Segment: | MidCap |
Average Daily Turnover: | Will be calculated by the French FSA |
Short name | ONXEO |
Orderbook ID: | 101775 |
Market Segment / no | OMX CPH Equities / 14 |
Tick Size /no | XCSE Equities, DKK / 7 |
MIC Code | XCSE |
Industry Classification Benchmark (ICB)
4000 | Health Care |
4500 | Health Care |
For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66